- ►asnjournals.org AB Shoben, KD Rudser, IH de Boer, B Young … - Journal of the American Society of Nephrology, 2008 - Am Soc Nephrol Parenteral vitamin D is associated with improved survival among long-term
hemodialysis patients. Among nondialyzed patients with chronic kidney disease
(CKD), oral activated vitamin D reduces parathyroid hormone levels, but the ... Cited by 37 - Related articles - All 10 versions
- ►ahajournals.org P Alborzi, NA Patel, C Peterson, JE Bills, DM … - Hypertension, 2008 - Am Heart Assoc Vitamin D receptor activation is associated with improved survival in patients
with chronic kidney disease, but the mechanism of this benefit is unclear. To
better understand the effects of vitamin D on endothelial function, blood ... Cited by 19 - Related articles - All 3 versions
DL Regidor, CP Kovesdy, R Mehrotra, M … - J Am Soc Nephrol, 2008 - Am Soc Nephrol ABSTRACT Several observational studies have demonstrated that serum levels of
minerals and parathyroid hormone (PTH) have U- or J-shaped associations with
mortality in maintenance hemodialysis patients, but the relationship ... Cited by 13 - Related articles - All 8 versions
- ►oxfordjournals.org F Tentori, JM Albert, EW Young, MJ Blayney, … - Nephrology Dialysis Transplantation, 2008 - ERA-EDTA Background. Retrospective studies of haemodialysis patients from large dialysis
organizations in the United States have indicated that intravenous vitamin D may
be associated with a survival benefit. However, patients prescribed vitamin ... Cited by 12 - Related articles - All 4 versions
- ►asnjournals.org P Raggi, M Kleerekoper - Clinical Journal of the American Society of Nephrology, 2008 - Am Soc Nephrol 1,25-Dihydroxyvitamin D 3 levels begin to drop early in the course of kidney
disease, leading to elevated parathyroid hormone levels and disrupted mineral
metabolism. Impaired mineral metabolism seems to be associated not only ... Cited by 10 - Related articles - All 3 versions
N Koleganova, G Piecha, E Ritz, CP Schmitt, … - Kidney International, 2008 - nature.com Renal insufficiency increases cardiovascular risk, accelerates atherogenesis,
and causes vascular wall remodeling. Here we evaluated the effect of the
calcimimetic R-568 and non-hypercalcemic doses of calcitriol on vascular ... Cited by 8 - Related articles - All 4 versions
H Komaba, M Tanaka, M Fukagawa - Internal Medicine, 2008 - J-STAGE Disturbances in mineral and bone metabolism play a critical role in the
pathogenesis of cardiovascular complications in patients with chronic kidney
disease (CKD). The term “renal osteodystrophy” has recently been ... Cited by 7 - Related articles - All 3 versions
K Olgaard, E Lewin - Nephrology Dialysis Transplantation, 2008 - ERA-EDTA Nephrol Dial Transplant (2008) 1 of 4 doi: 10.1093/ndt/gfn142 ... Use (or
misuse) of vitamin D treatment in CKD and dialysis patients ... A recent
meta-analysis on vitamin D compounds in chronic kidney disease [1] and an ... Cited by 6 - Related articles - BL Direct
- ►asnjournals.org CS Shinaberger, JD Kopple, CP Kovesdy, CJ … - Clinical Journal of the American Society of Nephrology, 2008 - Am Soc Nephrol Background and objectives: Several observational studies have indicated that
vitamin D receptor activators (VDRA), including paricalcitol, are associated
with greater survival in maintenance hemodialysis (MHD) patients; however, ... Cited by 5 - Related articles - All 3 versions
- ►asnjournals.org S Fishbane, WB Shapiro, DB Corry, SL Vicks … - Clinical Journal of the American Society of Nephrology, 2008 - Am Soc Nephrol Results: Of 173 subjects enrolled, 83% of Cinacalcet-D and 67% of Flex-D
subjects completed the study. A greater proportion of Cinacalcet-D versus Flex-D
subjects had a 30% reduction in parathyroid hormone (PTH) (68% versus 36%, ... Cited by 5 - Related articles - All 3 versions
